Literature DB >> 11861322

Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors.

M C H Ko1, N N Naughton, J R Traynor, M S Song, J H Woods, K C Rice, A T McKnight.   

Abstract

1. Orphanin FQ (OFQ), an endogenous peptide for ORL1 receptors, has been identified. Although the actions of OFQ have much in common with those of opioid peptides at the cellular level, behavioral studies in rodents seem conflicting. 2. The aim of this study was to investigate the potential pronociceptive or antinociceptive function of peripheral ORL1 receptors in primates. Experiments were conducted to verify whether local administration of OFQ can attenuate capsaicin-induced nociception and whether peripheral ORL1 receptors selectively mediate the local action of OFQ in monkeys. 3. Capsaicin (100 microg) was administered subcutaneously in the tail to locally evoke a nociceptive response (thermal allodynia/hyperalgesia), which was manifested as a reduced tail-withdrawal latency in normally innocuous 46 degreeC warm water. 4. Co-administration of OFQ (1--30 microg) with capsaicin in the tail dose-dependently inhibited thermal nociception. However, a locally effective dose of OFQ (30 microg), when applied in the back, did not inhibit capsaicin-induced nociception. 5. OFQ-induced local antinociception was antagonized by a small dose (10 microg) of J-113397, a selective ORL1 receptor antagonist, in the tail. Similarly, s.c. administration of 10 microg of J-113397 in the back did not antagonize local antinociception of OFQ. 6. In addition, s.c. administration of either OFQ or J-113397 in the tail alone did not change its thermal nociceptive threshold. Local administration of opioid receptor antagonists selective for mu, kappa, and delta opioid receptors did not antagonize OFQ-induced local antinociception. Local administration of J-113397 also did not interfere with the local actions of mu, kappa, and delta opioid agonists in the tail. 7. These results provide the first functional evidence that activation of peripheral ORL1 receptors produces thermal antinociception in primates and this action is independent of antinociception produced at classical opioid receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861322      PMCID: PMC1573199          DOI: 10.1038/sj.bjp.0704535

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  The capsaicin receptor: a heat-activated ion channel in the pain pathway.

Authors:  M J Caterina; M A Schumacher; M Tominaga; T A Rosen; J D Levine; D Julius
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

2.  Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals.

Authors:  Z Helyes; J Németh; E Pintér; J Szolcsányi
Journal:  Br J Pharmacol       Date:  1997-06       Impact factor: 8.739

Review 3.  The orphan opioid receptor and its endogenous ligand--nociceptin/orphanin FQ.

Authors:  G Henderson; A T McKnight
Journal:  Trends Pharmacol Sci       Date:  1997-08       Impact factor: 14.819

4.  Prejunctional modulation by nociceptin of nerve-mediated inotropic responses in guinea-pig left atrium.

Authors:  S Giuliani; C A Maggi
Journal:  Eur J Pharmacol       Date:  1997-08-13       Impact factor: 4.432

5.  Alfentanil, but not amitriptyline, reduces pain, hyperalgesia, and allodynia from intradermal injection of capsaicin in humans.

Authors:  J C Eisenach; D D Hood; R Curry; C Tong
Journal:  Anesthesiology       Date:  1997-06       Impact factor: 7.892

6.  Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys.

Authors:  M C Ko; K J Willmont; A Burritt; V J Hruby; J H Woods
Journal:  Eur J Pharmacol       Date:  2000-08-18       Impact factor: 4.432

7.  In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.

Authors:  S Ozaki; H Kawamoto; Y Itoh; M Miyaji; T Azuma; D Ichikawa; H Nambu; T Iguchi; Y Iwasawa; H Ohta
Journal:  Eur J Pharmacol       Date:  2000-08-18       Impact factor: 4.432

8.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor.

Authors:  M J Caterina; A Leffler; A B Malmberg; W J Martin; J Trafton; K R Petersen-Zeitz; M Koltzenburg; A I Basbaum; D Julius
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

Review 9.  Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more.

Authors:  T Darland; M M Heinricher; D K Grandy
Journal:  Trends Neurosci       Date:  1998-05       Impact factor: 13.837

10.  The role of peripheral mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys.

Authors:  M C Ko; E R Butelman; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

View more
  8 in total

1.  Effect of the blockade of mu1-opioid and 5HT2A-serotonergic/alpha1-noradrenergic receptors on sweet-substance-induced analgesia.

Authors:  E C C Rebouças; E N Segato; R Kishi; R L Freitas; M Savoldi; S Morato; N C Coimbra
Journal:  Psychopharmacology (Berl)       Date:  2004-12-10       Impact factor: 4.530

Review 2.  Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists.

Authors:  W Schröder; D G Lambert; M C Ko; T Koch
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

3.  Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channel regulation.

Authors:  Rhian M Evans; Haitao You; Shahid Hameed; Christophe Altier; Alexandre Mezghrani; Emmanuel Bourinet; Gerald W Zamponi
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

4.  Nonphotic entrainment of the circadian body temperature rhythm by the selective ORL1 receptor agonist W-212393 in rats.

Authors:  Koji Teshima; Masanori Minoguchi; Sayuri Tounai; Atsuyuki Ashimori; Junichi Eguchi; Charles N Allen; Shigenobu Shibata
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

5.  Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.

Authors:  Mei-Chuan Ko; Norah N Naughton
Journal:  J Pain       Date:  2009-02-23       Impact factor: 5.820

6.  Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain.

Authors:  Devki D Sukhtankar; Heeseung Lee; Kenner C Rice; Mei-Chuan Ko
Journal:  Psychopharmacology (Berl)       Date:  2013-11-12       Impact factor: 4.530

7.  Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.

Authors:  Mei-Chuan Ko; James H Woods; William E Fantegrossi; Chad M Galuska; Jürgen Wichmann; Eric P Prinssen
Journal:  Neuropsychopharmacology       Date:  2009-03-11       Impact factor: 7.853

Review 8.  Translational value of non-human primates in opioid research.

Authors:  Huiping Ding; Mei-Chuan Ko
Journal:  Exp Neurol       Date:  2021-01-14       Impact factor: 5.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.